News
Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.
The move makes Moderna’s vaccine, called Spikevax, the first COVID shot for kids in the U.S. to be fully approved, rather ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease ...
Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...
The US Food and Drug Administration (FDA) has approved US mRNA specialist Moderna supplemental Biologics License Application ...
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...
StockStory.org on MSN1d
Why Moderna (MRNA) Stock Is Up TodayWhat Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food ...
Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results